Association of Multiple Developmental Defects and Embryonic Lethality with Loss of Microsomal NADPH-Cytochrome P450 Oxidoreductase
Open accessThe DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Abstract
The microsomal flavoprotein NADPH-cytochrome P450 oxidoreductase (CYPOR) is believed to function as the primary, if not sole, electron donor for the microsomal cytochrome P450 mixed-function oxidase system. Development of the mammalian embryo is dependent upon temporally and spatially regulated expression of signaling factors, many of which are synthesized and/or degraded via the cytochromes P450 and other pathways involving NADPH-cytochrome P450 oxidoreductase as the electron donor. Expression of CYPOR as early as the two-cell stage of embryonic development (The Institute for Genomic Research Mouse Gene Index, version 5.0, www.tigr.org/tdb/mgi) suggests that CYPOR is essential for normal cellular functions and/or early embryogenesis. Targeted deletion of the translation start site and membrane-binding domain of CYPOR abolished microsomal CYPOR expression and led to production of a truncated, 66-kDa protein localized to the cytoplasm. Although early embryogenesis was not affected, a variety of embryonic defects was observable by day 10.5 of gestation, leading to lethality by day 13.5. Furthermore, a deficiency of heterozygotes was observed in 2-week-old mice as well as late gestational age embryos, suggesting that loss of one CYPOR allele produced some embryonic lethality. CYPOR -/- embryos displayed a marked friability, consistent with defects in cell adhesion. Ninety percent of CYPOR -/- embryos isolated at days 10.5 or 11.5 of gestation could be classified as either Type I, characterized by grossly normal somite formation but having neural tube, cardiac, eye, and limb abnormalities, or Type II, characterized by a generalized retardation of development after approximately day 8.5 of gestation. No CYPOR -/- embryos were observed after day 13.5 of gestation. These studies demonstrate that loss of microsomal CYPOR does not block early embryonic development but is essential for progression past mid-gestation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“No PORD patient carrying null mutations on both alleles has been described so far, suggesting incompatibility of such genotype with postnatal life, similar to the observation of early fetal death in the murine por deletion model (19, 20).”
From Genotype-Phenotype Analysis in Congenital Adrenal Hyperplasia due to P450 Oxidoreductase Deficiency (2012) · cites this paper as [19]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Type I embryos appeared normal until embryonic day 10.5 (E10.5) and had grossly normal somite formation, but they had cardiac, neural tube, eye, and limb defects and died by E13.5.”
From The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders (2011) · cites this paper as [310]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Type II embryos had generally retarded development by E8.5 and died shortly thereafter (310).”
From The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders (2011) · cites this paper as [310]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Consistent with this, genetically engineered POR-knockout mice die during fetal development (310,311).”
From The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders (2011) · cites this paper as [310]
The cited source says what the claim attributes to it.
In the citing paper
“Homozygous knockout mice had either of two phenotypes.”
From The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders (2011) · cites this paper as [310]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
THE HEME OXYGENASE SYSTEM:A Regulator of Second Messenger Gases
Maines, M. D. (1997) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.37.1.517 · Cited by 2,505
Derivation of completely cell culture-derived mice from early-passage embryonic stem cells.
Nagy, A., Rossant, J., Nagy, R., Abramow-Newerly, W., & Roder, J. C. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.18.8424 · Cited by 2,329
Current Protocols in Molecular Biology
Teplitz, R. (1989) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1989.03420090114049 · Cited by 1,803
Cytochrome P450: Structure, mechanism, and biochemistry
Pryor, W. A. (1996) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(96)83807-x · Cited by 1,598 · cited 1×
“NADPH-cytochrome P450 oxidoreductase (CYPOR) is an essential component of the microsomal P450 mixed-function oxidase system (1), mediating electron transfer from NADPH to the cytochromes P450, and a variety of other acceptors, including heme oxygenase (2), fatty acid elongase (3), cytochrome b5 (4) and squalene monoxy…”
BackgroundCholesterol Modification of Hedgehog Signaling Proteins in Animal Development
Porter, J. A., Young, K. E., & Beachy, P. A. (1996) · Science · doi:10.1126/science.274.5285.255 · Cited by 1,360
Burke, M. D., Thompson, S., Elcombe, C. R., Halpert, J., Haaparanta, T., & Mayer, R. T. (1985) · Biochemical Pharmacology · doi:10.1016/0006-2952(85)90355-7 · Cited by 1,275
Functional genomic analysis of cell division in C. elegans using RNAi of genes on chromosome III
Gönczy, P., Echeverri, C., Oegema, K., Coulson, A., Jones, S. J. M., Copley, R. R., Duperon, J., Oegema, J., Brehm, M., Cassin, E., et al. (2000) · Nature · doi:10.1038/35042526 · Cited by 867
Retinoids in Embryonal Development
Ross, S. A., McCaffery, P. J., Drager, U. C., & De Luca, L. M. (2000) · Physiological Reviews · doi:10.1152/physrev.2000.80.3.1021 · Cited by 866
Abu-Abed, S., Dollé, P., Metzger, D., Beckett, B., Chambon, P., & Petkovich, M. (2001) · Genes & Development · doi:10.1101/gad.855001 · Cited by 578
Sakai, Y., Meno, C., Fujii, H., Nishino, J., Shiratori, H., Saijoh, Y., Rossant, J., & Hamada, H. (2001) · Genes & Development · doi:10.1101/gad.851501 · Cited by 456
Fujii, H. (1997) · The EMBO Journal · doi:10.1093/emboj/16.14.4163 · Cited by 353
Shen, A. L., Porter, T. D., Wilson, T. E., & Kasper, C. B. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)83274-4 · Cited by 264
Self-citationSchacter, B. A., Nelson, E. B., Marver, H. S., & Masters, B. S. S. (1972) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)45183-1 · Cited by 253
White, J. A., Ramshaw, H., Taimi, M., Stangle, W., Zhang, A., Everingham, S., Creighton, S., Tam, S.-P., Jones, G., & Petkovich, M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.120161397 · Cited by 248
Cytochrome b5 reduction by NADPH-cytochrome P-450 reductase.
Enoch, H. G., & Strittmatter, P. (1979) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)86797-2 · Cited by 199
Peoples, R., Franke, Y., Wang, Y.-K., Pérez-Jurado, L., Paperna, T., Cisco, M., & Francke, U. (2000) · The American Journal of Human Genetics · doi:10.1086/302722 · Cited by 181
Strömstedt, M., Rozman, D., & Waterman, M. R. (1996) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1996.0193 · Cited by 162
Solubilization and partial characterization of rat liver squalene epoxidase
Ono, T., & Bloch, K. (1975) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)41847-4 · Cited by 157
Embryonic Lethality and Defective Neural Tube Closure in Mice Lacking Squalene Synthase
Tozawa, R.-I., Ishibashi, S., Osuga, J.-I., Yagyu, H., Oka, T., Chen, Z., Ohashi, K., Perrey, S., Shionoiri, F., Yahagi, N., et al. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.43.30843 · Cited by 125
Simmons, D. L., Lalley, P. A., & Kasper, C. B. (1985) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)89763-0 · Cited by 122
Self-citationBlack, S. D., French, J. S., Williams, C. H., & Coon, M. J. (1979) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(79)91238-5 · Cited by 115
Developmental onset of mixed-function oxidase activity in preimplantation mouse embryos.
Filler, R., & Lew, K. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.11.6991 · Cited by 111
Lamb, D. C., Kelly, D. E., Manning, N. J., Kaderbhai, M. A., & Kelly, S. L. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)01548-3 · Cited by 91
Porter, T. D., Beck, T. W., & Kasper, C. B. (1990) · Biochemistry · doi:10.1021/bi00494a009 · Cited by 85
Self-citationTruan, G., Epinat, J.-C., Rougeulle, C., Cullin, C., & Pompon, D. (1994) · Gene · doi:10.1016/0378-1119(94)90366-2 · Cited by 77
Ilan, Z., Ilan, R., & Cinti, D. L. (1981) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)68742-9 · Cited by 75
Genetic Defects in Postsqualene Cholesterol Biosynthesis
Moebius, F. F., Fitzky, B. U., & Glossmann, H. H. (2000) · Trends in Endocrinology and Metabolism · doi:10.1016/s1043-2760(00)00235-6 · Cited by 66
Multiple forms of NADPH-cytochrome P450 reductase in higher plants
Benveniste, I., Lesot, A., Hasenfratz‐Sauder, M., Kochs, G., & Durst, F. (1991) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(91)91954-b · Cited by 59
Preimplantation mouse blastocysts fail to express CYP genes required for estrogen biosynthesis
Strömstedt, M., Keeney, D. S., Waterman, M. R., Paria, B. C., Conley, A. J., & Dey, S. K. (1996) · Molecular Reproduction and Development · doi:10.1002/(sici)1098-2795(199604)43:4<428::aid-mrd4>3.0.co;2-r · Cited by 45
Lalwani, S. I., Saymé, N., Vigue, L. C., Corrales, M., & Huszar, G. B. (1996) · Molecular Reproduction and Development · doi:10.1002/(sici)1098-2795(199604)43:4<495::aid-mrd12>3.0.co;2-z · Cited by 27
O’Leary, K. A., Beck, T. W., & Kasper, C. B. (1994) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1994.1192 · Cited by 27
Self-citationCytochromes P450 in synthesis of steroid hormones, bile acids, vitamin D3 and cholesterol.
Pikuleva, I. A., & Waterman, M. R. (1999) · PubMed · Cited by 25
Protein and Gene Structure and Regulation of NADPH-Cytochrome P450 Oxidoreductase
Shen, A. L., & Kasper, C. B. (1993) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-77763-9_3 · Cited by 24
Self-citationThe Role of NADPH-Cytochrome c (P-450) Reductase in Detoxication
Masters, B. S. S. (1980) · Elsevier eBooks · doi:10.1016/b978-0-12-380001-5.50014-1 · Cited by 20
Anandatheerthavarada, H. K., Amuthan, G., Biswas, G., Robin, M., Murali, R., Waterman, M. R., & Avadhani, N. G. (2001) · The EMBO Journal · doi:10.1093/emboj/20.10.2394 · Cited by 18
Research works printed but not linked: 1
- Pikuleva, 1999, Mol. Aspects Med., 20, 33
Cited by
Zanger, U. M., & Schwab, M. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2012.12.007 · Cited by 4,169
“Complete deletion of the por gene in mouse is embryonically lethal most likely due to deficient adrenocortical steroidogenesis (Shen et al., 2002; Otto et al., 2003).”
BackgroundThe Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders
Miller, W. L., & Auchus, R. J. (2011) · Endocrine Reviews · doi:10.1210/er.2010-0013 · Cited by 2,458
Yan, B., Ai, Y., Sun, Q., Ma, Y., Cao, Y., Wang, J., Zhang, Z., & Wang, X. (2021) · Molecular Cell · doi:10.1016/j.molcel.2020.11.024 · Cited by 617
Mutant P450 oxidoreductase causes disordered steroidogenesis with and without Antley-Bixler syndrome
Flück, C. E., Tajima, T., Pandey, A. V., Arlt, W., Okuhara, K., Verge, C. F., Jabs, E. W., Mendonça, B. B., Fujieda, K., & Miller, W. L. (2004) · Nature Genetics · doi:10.1038/ng1300 · Cited by 509
Malformation syndromes caused by disorders of cholesterol synthesis
Porter, F. D., & Herman, G. E. (2011) · Journal of Lipid Research · doi:10.1194/jlr.r009548 · Cited by 473
Metadata
- Authors
- Shen, A. L., O'Leary, K. A., & Kasper, C. B.
- Affiliations
- University of Wisconsin–Madison (US)
- Corresponding author
- Kasper, Charles B.
- ORCID
- Shen, Anna L.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2002-02
- Volume
- 277
- Issue
- 8
- Pages
- 6536-6541
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2019819564
- Semantic Scholar
- 023cbff56807eedc0abd9435cefe2166ffaa2b1f
- Cited by
- 225
- References
- 34
- Citations by year
- 2026: 3 · 2025: 5 · 2024: 3 · 2023: 6 · 2022: 6 · 2021: 16 · 2020: 8 · 2019: 4 · 2018: 7 · 2017: 4 · 2016: 5 · 2015: 10 · 2014: 13 · 2013: 16 · 2012: 15
- FWCI
- 7.12
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 6836 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- University of Wisconsin-Madison
- University of Utah
- National Institutes of Health (5p30ca007175-36, 5p30es009090-04, CA22484)
- National Cancer Institute (CA-07175, CA 22484, P01CA022484)
- National Institute of Environmental Health Sciences (P30 ES09090-04)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Developmental Biology and Gene Regulation
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Pharmacological Effects and Toxicity Studies
- Keywords
- NADPH-cytochrome P450 reductase, embryonic lethality, developmental defects, mixed function oxidase, truncated protein, cell adhesion, neural tube defects, cardiac defects, eye defects, limb malformations, somitogenesis, mouse embryo, heterozygote deficiency
- MeSH terms
- Abnormalities, Multiple, Animals, Crosses, Genetic, Fetal Death, Gestational Age, Heart Defects, Congenital, NADPH-Ferrihemoprotein Reductase, Neural Tube Defects, Phenotype, Restriction Mapping, Sequence Deletion, Mice, Knockout, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.